
pmc: PMC6365021 , PMC5182010
After the publication of the article, the authors realize that they overlooked stating that the author Magda Kucia was the recipient of an OPUS grant (grant no. UMO‑2016/21/B/NZ4/00201). Therefore, the Acknowledgements section of the paper should have read as follows (the added text is highlighted in bold): "This study was supported by NIH grants 2R01 DK074720 and R01HL112788, the Stella and Henry Endowment, and NCN Harmonia grant UMO‑2014/14/M/NZ3/00475 to M.Z.R., and OPUS grant UMO‑2016/21/B/NZ4/00201 to M.K." The authors regret their oversight in failing to include this information in the Acknowledgements section of their paper. [the original article was published in International Journal of Oncology 50: 317-328, 2017; DOI: 10.3892/ijo.2016.3787].
Lung Neoplasms, Heme oxygenase-1 - biosynthesis, Protoporphyrins, p38 Mitogen-Activated Protein Kinases, Mice, Cell Movement, Follicle stimulating hormone - administration & dosage, Luteinizing hormone - administration & dosage, Animals, Humans, Pituitary gland - metabolism, Heme oxygenase-1 - antagonists & inhibitors, Heme oxygenase-1 - genetics, Cell Proliferation, Gene expression regulation, Lung neoplasms - drug therapy, Protoporphyrins - administration & dosage, Chemotaxis, Prolactin - metabolism, neoplastic - drug effects, Cell movement - drug effects, Lung neoplasms - genetics, Articles, Luteinizing Hormone, Luteinizing hormone - metabolism, p38 mitogen-activated protein kinases - genetics, Prolactin, Gene Expression Regulation, Neoplastic, Chemotaxis - drug effects, Cell proliferation - drug effects, Pituitary Gland, Lung neoplasms - pathology, Follicle stimulating hormone - metabolism, Prolactin - administration & dosage, Follicle Stimulating Hormone, Corrigendum, Heme Oxygenase-1
Lung Neoplasms, Heme oxygenase-1 - biosynthesis, Protoporphyrins, p38 Mitogen-Activated Protein Kinases, Mice, Cell Movement, Follicle stimulating hormone - administration & dosage, Luteinizing hormone - administration & dosage, Animals, Humans, Pituitary gland - metabolism, Heme oxygenase-1 - antagonists & inhibitors, Heme oxygenase-1 - genetics, Cell Proliferation, Gene expression regulation, Lung neoplasms - drug therapy, Protoporphyrins - administration & dosage, Chemotaxis, Prolactin - metabolism, neoplastic - drug effects, Cell movement - drug effects, Lung neoplasms - genetics, Articles, Luteinizing Hormone, Luteinizing hormone - metabolism, p38 mitogen-activated protein kinases - genetics, Prolactin, Gene Expression Regulation, Neoplastic, Chemotaxis - drug effects, Cell proliferation - drug effects, Pituitary Gland, Lung neoplasms - pathology, Follicle stimulating hormone - metabolism, Prolactin - administration & dosage, Follicle Stimulating Hormone, Corrigendum, Heme Oxygenase-1
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
